222 related articles for article (PubMed ID: 9672256)
1. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.
He Y; Zeng Q; Drenning SD; Melhem MF; Tweardy DJ; Huang L; Grandis JR
J Natl Cancer Inst; 1998 Jul; 90(14):1080-7. PubMed ID: 9672256
[TBL] [Abstract][Full Text] [Related]
2. TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo.
Endo S; Zeng Q; Burke NA; He Y; Melhem MF; Watkins SF; Lango MN; Drenning SD; Huang L; Rubin Grandis J
Gene Ther; 2000 Nov; 7(22):1906-14. PubMed ID: 11127578
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter.
He Y; Huang L
Cancer Res; 1997 Sep; 57(18):3993-9. PubMed ID: 9307284
[TBL] [Abstract][Full Text] [Related]
4. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Thomas SM; Ogagan MJ; Freilino ML; Strychor S; Walsh DR; Gooding WE; Grandis JR; Zamboni WC
Mol Pharmacol; 2008 Mar; 73(3):627-38. PubMed ID: 18025070
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR
Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
[TBL] [Abstract][Full Text] [Related]
8. Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
Bauman JE; Duvvuri U; Thomas S; Gooding WE; Clump DA; Karlovits B; Wehbe A; Miller FR; Kim S; Sen M; Heron DE; Grandis JR; Argiris A
Cancer; 2018 Oct; 124(19):3881-3889. PubMed ID: 30291796
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms.
Lai SY; Koppikar P; Thomas SM; Childs EE; Egloff AM; Seethala RR; Branstetter BF; Gooding WE; Muthukrishnan A; Mountz JM; Lui VW; Shin DM; Agarwala SS; Johnson R; Couture LA; Myers EN; Johnson JT; Mills G; Argiris A; Grandis JR
J Clin Oncol; 2009 Mar; 27(8):1235-42. PubMed ID: 19204206
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
Riedel F; Götte K; Hörmann K; Grandis JR
Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
[TBL] [Abstract][Full Text] [Related]
11. DMP-1 promoter-associated antisense strand non-coding RNA, panRNA-DMP-1, physically associates with EGFR to repress EGF-induced squamous cell carcinoma migration.
Suzuki S; Yuan H; Hirata-Tsuchiya S; Yoshida K; Sato A; Nemoto E; Shiba H; Yamada S
Mol Cell Biochem; 2021 Apr; 476(4):1673-1690. PubMed ID: 33420898
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
Stabile LP; Lyker JS; Huang L; Siegfried JM
Gene Ther; 2004 Feb; 11(3):325-35. PubMed ID: 14737093
[TBL] [Abstract][Full Text] [Related]
13. Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma.
Blackwell JL; Miller CR; Douglas JT; Li H; Reynolds PN; Carroll WR; Peters GE; Strong TV; Curiel DT
Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):856-63. PubMed ID: 10448731
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells.
Ping Y; Jian Z; Yi Z; Huoyu Z; Feng L; Yuqiong Y; Shixi L
Med Oncol; 2010 Sep; 27(3):715-21. PubMed ID: 19653138
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer.
Rubin Grandis J; Zeng Q; Drenning SD
Laryngoscope; 2000 May; 110(5 Pt 1):868-74. PubMed ID: 10807365
[TBL] [Abstract][Full Text] [Related]
16. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Tortora G
J Natl Cancer Inst; 1998 Jul; 90(14):1087-94. PubMed ID: 9672257
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor expression in human colon and colon carcinomas: anti-sense epidermal growth factor receptor RNA down-regulates the proliferation of human colon cancer cells.
Rajagopal S; Huang S; Moskal TL; Lee BN; el-Naggar AK; Chakrabarty S
Int J Cancer; 1995 Sep; 62(6):661-7. PubMed ID: 7558411
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.
Eke I; Zscheppang K; Dickreuter E; Hickmann L; Mazzeo E; Unger K; Krause M; Cordes N
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25663685
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.
Grandis JR; Drenning SD; Zeng Q; Watkins SC; Melhem MF; Endo S; Johnson DE; Huang L; He Y; Kim JD
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4227-32. PubMed ID: 10760290
[TBL] [Abstract][Full Text] [Related]
20. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Grandis JR; Chakraborty A; Zeng Q; Melhem MF; Tweardy DJ
J Cell Biochem; 1998 Apr; 69(1):55-62. PubMed ID: 9513046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]